Exclusive

Publication

Byline

Location

US Patent Issued to ImmunityBio on July 28 for "Multi-chain chimeric polypeptides and uses thereof" (Florida Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,295, issued on July 28, was assigned to ImmunityBio Inc. (San Diego). "Multi-chain chimeric polypeptides and uses thereof" was invented by ... Read More


US Patent Issued to University Health Network on July 28 for "T cell receptors and methods of use thereof" (Canadian Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,296, issued on July 28, was assigned to University Health Network (Toronto). "T cell receptors and methods of use thereof" was invented by ... Read More


US Patent Issued to UCL Business on July 28 for "Engineered regulatory T cell" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,297, issued on July 28, was assigned to UCL Business Ltd (London). "Engineered regulatory T cell" was invented by Hans Stauss (London), Sha... Read More


US Patent Issued to Institute of Microbiology, Chinese Academy of Sciences on July 28 for "Screening and antitumor use of KRAS mutation specific T cell receptor" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,298, issued on July 28, was assigned to Institute of Microbiology, Chinese Academy of Sciences (Beijing). "Screening and antitumor use of K... Read More


US Patent Issued to Alpine Immune Sciences on July 28 for "Variant ICOS ligand immunomodulatory proteins and related compositions and methods" (Washington Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,299, issued on July 28, was assigned to Alpine Immune Sciences Inc. (Seattle). "Variant ICOS ligand immunomodulatory proteins and related c... Read More


US Patent Issued to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY on July 28 for "Method for treating SARS-COV-2 infectious disease" (South Korean Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,300, issued on July 28, was assigned to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (Suwon-si, South Korea). "Method for treatin... Read More


US Patent Issued to ALKAHEST on July 28 for "Methods of improving retina-associated disease outcome using CCR3-inhibitors" (American, Polish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,301, issued on July 28, was assigned to ALKAHEST INC. (San Carlos, Calif.). "Methods of improving retina-associated disease outcome using C... Read More


US Patent Issued to Genentech on July 28 for "Uses of IL-13 antagonists for treating atopic dermatitis" (California, Pennsylvania Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,302, issued on July 28, was assigned to Genentech Inc. (South San Francisco, Calif.). "Uses of IL-13 antagonists for treating atopic dermat... Read More


US Patent Issued to QYUNS THERAPEUTICS on July 28 for "Anti-human interleukin 23 monoclonal antibody and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,303, issued on July 28, was assigned to QYUNS THERAPEUTICS Co. LTD. (Jiangsu, China). "Anti-human interleukin 23 monoclonal antibody and ap... Read More


US Patent Issued to UCB BIOPHARMA on July 28 for "Antibodies against interleukin-22" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,304, issued on July 28, was assigned to UCB BIOPHARMA SRL (Brussels). "Antibodies against interleukin-22" was invented by Joseph Michael Da... Read More